Takara Bio USA Holdings, Inc. completes acquisition of WaferGen Bio-systems, Inc.

Takara Bio USA Holdings, Inc. completes acquisition of WaferGen Bio-systems, Inc. Mountain View, CA—March 1, 2017—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of WaferGen Bio-systems, Inc. (“WaferGen”), WaferGen has become a wholly-owned subsidiary of TBUSH as of February 28, 2017 (US local time). Under the merger agreement executed with... Read more

Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business

CAMBRIDGE, UK – 27 February, 2017 – Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners (Amadeus) participated alongside new investor, Parkwalk Advisors (Parkwalk). Congenica will use the Series B... Read more

Promega Corporation brings high-performance DNA analysis to the benchtop with new Spectrum Compact CE instrument

Madison, WI USA. (February 14, 2017) (February 14, 2017) Soon scientists will be able to perform efficient DNA analysis right at their bench. Promega Corporation has announced the development of a benchtop capillary electrophoresis (CE) instrument in collaboration with Hitachi High-Technologies Corporation. The Spectrum Compact CE System meets small batch and single sample needs in... Read more

Seegene Develops New Normalization Software Technology for Molecular Diagnosis

14 Feb, 2017, 09:00 ET SEOUL, South Korea, Feb. 14, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies today announced that it has developed a new software technology that can normalize test results of real-time PCR molecular diagnosis systems. This new innovative technology calibrates test results by correcting signal variations... Read more

Swift Biosciences Launches Novel Long-Insert Library Kit to Improve Data Quality on Pacific Biosciences® Sequencing Platforms

Results from Mount Sinai, Washington University, and Cold Spring Harbor Laboratories to be presented at AGBT 2017 General Meeting (ANN ARBOR, Mich. – February 14, 2017) Swift Biosciences today announced the commercial release of its Accel-NGS® XL Library Prep Kit, the fastest sequencing solution for whole genome sequencing on Pacific Biosciences (PacBio®) platforms. This library preparation kit, specially... Read more

SMRT Sequencing to be Featured in More Than 35 Presentations at the Annual AGBT Conference

Customers Demonstrate Value of PacBio Long-Read Solutions for Resolving Structural Variants, Targeted Sequencing and Isoform Sequencing ApplicationsMENLO PARK, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that data using its Single Molecule, Real-Time (SMRT®) Sequencing technology, including results from its Sequel™ System, will be featured in more than... Read more

SMRT Sequencing to be Featured in More Than 35 Presentations at the Annual AGBT Conference

Customers Demonstrate Value of PacBio Long-Read Solutions for Resolving Structural Variants, Targeted Sequencing and Isoform Sequencing ApplicationsMENLO PARK, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that data using its Single Molecule, Real-Time (SMRT®) Sequencing technology, including results from its Sequel™ System, will be featured in more than... Read more

10x Genomics Bolsters Commercial Leadership with the Appointment of Bradford J. Crutchfield as Chief Commercial Officer

PLEASANTON, Calif. – February 9, 2017 – 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced the appointment of Bradford J. Crutchfield as chief commercial officer of the company. Mr. Crutchfield will oversee global sales, marketing, business development and customer support. John Pouk, the company’s interim chief... Read more

Swift Biosciences Expands Team, Hires Vice President of Marketing

Ann Arbor, MI, February 8, 2017 – Swift Biosciences, today announced that it has hired Candia Brown as Vice President of Global Marketing. Brown brings over 25 years of biotechnology experience including product development, product management and market development. “Candia‘s deep expertise in the genomic tools market and associated applications coupled to her incredibly strong track record with... Read more

Integrated DNA Technologies acquires oligo manufacturing business of GeneWorks (Australia)

IDT expands its capacity for direct sales of genomic products in Asia-Pacific region SKOKIE, IL (February 8, 2017) – Integrated DNA Technologies (IDT), through its Singapore subsidiary, today completed the acquisition of the oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia. This acquisition sees IDT expand its reach in the Asia-Pacific region, following... Read more